147 related articles for article (PubMed ID: 8595639)
1. Results of a survey of children with acute bacterial conjunctivitis treated with trimethoprim-polymyxin B ophthalmic solution.
Wagner RS
Clin Ther; 1995; 17(5):875-81. PubMed ID: 8595639
[TBL] [Abstract][Full Text] [Related]
2. A single-blinded randomized clinical trial comparing polymyxin B-trimethoprim and moxifloxacin for treatment of acute conjunctivitis in children.
Williams L; Malhotra Y; Murante B; Laverty S; Cook S; Topa D; Hardy D; Wang H; Gigliotti F
J Pediatr; 2013 Apr; 162(4):857-61. PubMed ID: 23092529
[TBL] [Abstract][Full Text] [Related]
3. A multicenter comparison of polymyxin B sulfate/trimethoprim ophthalmic solution and moxifloxacin in the speed of clinical efficacy for the treatment of bacterial conjunctivitis.
Granet DB; Dorfman M; Stroman D; Cockrum P
J Pediatr Ophthalmol Strabismus; 2008; 45(6):340-9. PubMed ID: 19043945
[TBL] [Abstract][Full Text] [Related]
4. Trimethoprim-polymyxin B sulphate ophthalmic ointment versus chloramphenicol ophthalmic ointment in the treatment of bacterial conjunctivitis--a review of four clinical studies. The Trimethoprim-Polymyxin B Sulphate Ophthalmic Ointment Study Group.
J Antimicrob Chemother; 1989 Feb; 23(2):261-6. PubMed ID: 2540136
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three topical antimicrobials for acute bacterial conjunctivitis.
Lohr JA; Austin RD; Grossman M; Hayden GF; Knowlton GM; Dudley SM
Pediatr Infect Dis J; 1988 Sep; 7(9):626-9. PubMed ID: 2845348
[TBL] [Abstract][Full Text] [Related]
6. Trimethoprim-polymyxin B ophthalmic solution in the treatment of presumptive bacterial conjunctivitis--a multicentre trial of its efficacy versus neomycin-polymyxin B-gramicidin and chloramphenicol ophthalmic solutions.
Gibson JR
J Antimicrob Chemother; 1983 Mar; 11(3):217-21. PubMed ID: 6188739
[TBL] [Abstract][Full Text] [Related]
7. Trimethoprim-polymyxin B sulphate ophthalmic ointment in the treatment of bacterial conjunctivitis: a double-blind study versus chloramphenicol ophthalmic ointment.
Behrens-Baumann W; Quentin CD; Gibson JR; Calthrop JG; Harvey SG; Booth K
Curr Med Res Opin; 1988; 11(4):227-31. PubMed ID: 2850891
[TBL] [Abstract][Full Text] [Related]
8. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children.
Isenberg SJ; Apt L; Valenton M; Del Signore M; Cubillan L; Labrador MA; Chan P; Berman NG
Am J Ophthalmol; 2002 Nov; 134(5):681-8. PubMed ID: 12429243
[TBL] [Abstract][Full Text] [Related]
9. Trimethoprim-polymyxin B ophthalmic solution in treatment of surface ocular bacterial infections.
Nozik RA; Smolin G; Knowlton G; Austin R
Ann Ophthalmol; 1985 Dec; 17(12):746-8. PubMed ID: 2418736
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of trimethoprim-containing ophthalmic solutions in humans.
Lamberts DW; Buka T; Knowlton GM
Am J Ophthalmol; 1984 Jul; 98(1):11-6. PubMed ID: 6204534
[TBL] [Abstract][Full Text] [Related]
11. Moxifloxacin versus polymyxin B/trimethoprim sulfate in pediatric bacterial conjunctivitis.
Wagner RS
J Pediatr Ophthalmol Strabismus; 2008; 45(6):330. PubMed ID: 19043943
[No Abstract] [Full Text] [Related]
12. Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis.
van Rensburg SF; Gibson JR; Harvey SG; Burke CA
Pharmatherapeutica; 1982; 3(4):274-7. PubMed ID: 6292957
[TBL] [Abstract][Full Text] [Related]
13. Anaphylaxis to polymyxin B-trimethoprim eye drops.
Henao MP; Ghaffari G
Ann Allergy Asthma Immunol; 2016 Apr; 116(4):372. PubMed ID: 26922212
[No Abstract] [Full Text] [Related]
14. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children.
Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL
Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% compared with moxifloxacin ophthalmic solution 0.5% for treating bacterial conjunctivitis.
McDonald MB; Protzko EE; Brunner LS; Morris TW; Haas W; Paterno MR; Comstock TL; Usner DW
Ophthalmology; 2009 Sep; 116(9):1615-1623.e1. PubMed ID: 19643483
[TBL] [Abstract][Full Text] [Related]
16. New antibacterial drugs for topical ophthalmic use.
Yolton DP
Optom Clin; 1992; 2(4):59-72. PubMed ID: 1286241
[TBL] [Abstract][Full Text] [Related]
17. Short term oral cefixime therapy for treatment of bacterial conjunctivitis.
Wald ER; Greenberg D; Hoberman A
Pediatr Infect Dis J; 2001 Nov; 20(11):1039-42. PubMed ID: 11734708
[TBL] [Abstract][Full Text] [Related]
18. A clinical comparison of two formulations of tobramycin 0.3% eyedrops in the treatment of acute bacterial conjunctivitis.
Kernt K; Martinez MA; Bertin D; Stroman D; Cupp G; MartÃnez C; Tirado M; Guasch J;
Eur J Ophthalmol; 2005; 15(5):541-9. PubMed ID: 16167284
[TBL] [Abstract][Full Text] [Related]
19. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis.
Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT;
Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
Comstock TL; Paterno MR; Usner DW; Pichichero ME
Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
